Cargando…

Platinum sensitivity and DNA repair in a recently established panel of patient-derived ovarian carcinoma xenografts

A xenobank of patient-derived (PDX) ovarian tumor samples has been established consisting of tumors with different sensitivity to cisplatin (DDP), from very responsive to resistant. As the DNA repair pathway is an important driver in tumor response to DDP, we analyzed the mRNA expression of 20 genes...

Descripción completa

Detalles Bibliográficos
Autores principales: Guffanti, Federica, Fratelli, Maddalena, Ganzinelli, Monica, Bolis, Marco, Ricci, Francesca, Bizzaro, Francesca, Chilà, Rosaria, Sina, Federica Paola, Fruscio, Robert, Lupia, Michela, Cavallaro, Ugo, Cappelletti, Maria Rosa, Generali, Daniele, Giavazzi, Raffaella, Damia, Giovanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973859/
https://www.ncbi.nlm.nih.gov/pubmed/29872499
http://dx.doi.org/10.18632/oncotarget.25185
_version_ 1783326701053280256
author Guffanti, Federica
Fratelli, Maddalena
Ganzinelli, Monica
Bolis, Marco
Ricci, Francesca
Bizzaro, Francesca
Chilà, Rosaria
Sina, Federica Paola
Fruscio, Robert
Lupia, Michela
Cavallaro, Ugo
Cappelletti, Maria Rosa
Generali, Daniele
Giavazzi, Raffaella
Damia, Giovanna
author_facet Guffanti, Federica
Fratelli, Maddalena
Ganzinelli, Monica
Bolis, Marco
Ricci, Francesca
Bizzaro, Francesca
Chilà, Rosaria
Sina, Federica Paola
Fruscio, Robert
Lupia, Michela
Cavallaro, Ugo
Cappelletti, Maria Rosa
Generali, Daniele
Giavazzi, Raffaella
Damia, Giovanna
author_sort Guffanti, Federica
collection PubMed
description A xenobank of patient-derived (PDX) ovarian tumor samples has been established consisting of tumors with different sensitivity to cisplatin (DDP), from very responsive to resistant. As the DNA repair pathway is an important driver in tumor response to DDP, we analyzed the mRNA expression of 20 genes involved in the nucleotide excision repair, fanconi anemia, homologous recombination, base excision repair, mismatch repair and translesion repair pathways and the methylation patterns of some of these genes. We also investigated the correlation with the response to platinum-based therapy. The mRNA levels of the selected genes were evaluated by Real Time-PCR (RT-PCR) with ad hoc validated primers and gene promoter methylation by pyrosequencing. All the DNA repair genes were variably expressed in all 42 PDX samples analyzed, with no particular histotype-specific pattern of expression. In high-grade serous/endometrioid PDXs, the CDK12 mRNA expression levels positively correlated with the expression of TP53BP1, PALB2, XPF and POLB. High-grade serous/endometrioid PDXs with TP53 mutations had significantly higher levels of POLQ, FANCD2, RAD51 and POLB than high-grade TP53 wild type PDXs. The mRNA levels of CDK12, PALB2 and XPF inversely associated with the in vivo DDP antitumor activity; higher CDK12 mRNA levels were associated with a higher recurrence rate in ovarian patients with low residual tumor. These data support the important role of CDK12 in the response to a platinum based therapy in ovarian patients.
format Online
Article
Text
id pubmed-5973859
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-59738592018-06-05 Platinum sensitivity and DNA repair in a recently established panel of patient-derived ovarian carcinoma xenografts Guffanti, Federica Fratelli, Maddalena Ganzinelli, Monica Bolis, Marco Ricci, Francesca Bizzaro, Francesca Chilà, Rosaria Sina, Federica Paola Fruscio, Robert Lupia, Michela Cavallaro, Ugo Cappelletti, Maria Rosa Generali, Daniele Giavazzi, Raffaella Damia, Giovanna Oncotarget Research Paper A xenobank of patient-derived (PDX) ovarian tumor samples has been established consisting of tumors with different sensitivity to cisplatin (DDP), from very responsive to resistant. As the DNA repair pathway is an important driver in tumor response to DDP, we analyzed the mRNA expression of 20 genes involved in the nucleotide excision repair, fanconi anemia, homologous recombination, base excision repair, mismatch repair and translesion repair pathways and the methylation patterns of some of these genes. We also investigated the correlation with the response to platinum-based therapy. The mRNA levels of the selected genes were evaluated by Real Time-PCR (RT-PCR) with ad hoc validated primers and gene promoter methylation by pyrosequencing. All the DNA repair genes were variably expressed in all 42 PDX samples analyzed, with no particular histotype-specific pattern of expression. In high-grade serous/endometrioid PDXs, the CDK12 mRNA expression levels positively correlated with the expression of TP53BP1, PALB2, XPF and POLB. High-grade serous/endometrioid PDXs with TP53 mutations had significantly higher levels of POLQ, FANCD2, RAD51 and POLB than high-grade TP53 wild type PDXs. The mRNA levels of CDK12, PALB2 and XPF inversely associated with the in vivo DDP antitumor activity; higher CDK12 mRNA levels were associated with a higher recurrence rate in ovarian patients with low residual tumor. These data support the important role of CDK12 in the response to a platinum based therapy in ovarian patients. Impact Journals LLC 2018-05-15 /pmc/articles/PMC5973859/ /pubmed/29872499 http://dx.doi.org/10.18632/oncotarget.25185 Text en Copyright: © 2018 Guffanti et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Guffanti, Federica
Fratelli, Maddalena
Ganzinelli, Monica
Bolis, Marco
Ricci, Francesca
Bizzaro, Francesca
Chilà, Rosaria
Sina, Federica Paola
Fruscio, Robert
Lupia, Michela
Cavallaro, Ugo
Cappelletti, Maria Rosa
Generali, Daniele
Giavazzi, Raffaella
Damia, Giovanna
Platinum sensitivity and DNA repair in a recently established panel of patient-derived ovarian carcinoma xenografts
title Platinum sensitivity and DNA repair in a recently established panel of patient-derived ovarian carcinoma xenografts
title_full Platinum sensitivity and DNA repair in a recently established panel of patient-derived ovarian carcinoma xenografts
title_fullStr Platinum sensitivity and DNA repair in a recently established panel of patient-derived ovarian carcinoma xenografts
title_full_unstemmed Platinum sensitivity and DNA repair in a recently established panel of patient-derived ovarian carcinoma xenografts
title_short Platinum sensitivity and DNA repair in a recently established panel of patient-derived ovarian carcinoma xenografts
title_sort platinum sensitivity and dna repair in a recently established panel of patient-derived ovarian carcinoma xenografts
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973859/
https://www.ncbi.nlm.nih.gov/pubmed/29872499
http://dx.doi.org/10.18632/oncotarget.25185
work_keys_str_mv AT guffantifederica platinumsensitivityanddnarepairinarecentlyestablishedpanelofpatientderivedovariancarcinomaxenografts
AT fratellimaddalena platinumsensitivityanddnarepairinarecentlyestablishedpanelofpatientderivedovariancarcinomaxenografts
AT ganzinellimonica platinumsensitivityanddnarepairinarecentlyestablishedpanelofpatientderivedovariancarcinomaxenografts
AT bolismarco platinumsensitivityanddnarepairinarecentlyestablishedpanelofpatientderivedovariancarcinomaxenografts
AT riccifrancesca platinumsensitivityanddnarepairinarecentlyestablishedpanelofpatientderivedovariancarcinomaxenografts
AT bizzarofrancesca platinumsensitivityanddnarepairinarecentlyestablishedpanelofpatientderivedovariancarcinomaxenografts
AT chilarosaria platinumsensitivityanddnarepairinarecentlyestablishedpanelofpatientderivedovariancarcinomaxenografts
AT sinafedericapaola platinumsensitivityanddnarepairinarecentlyestablishedpanelofpatientderivedovariancarcinomaxenografts
AT frusciorobert platinumsensitivityanddnarepairinarecentlyestablishedpanelofpatientderivedovariancarcinomaxenografts
AT lupiamichela platinumsensitivityanddnarepairinarecentlyestablishedpanelofpatientderivedovariancarcinomaxenografts
AT cavallarougo platinumsensitivityanddnarepairinarecentlyestablishedpanelofpatientderivedovariancarcinomaxenografts
AT cappellettimariarosa platinumsensitivityanddnarepairinarecentlyestablishedpanelofpatientderivedovariancarcinomaxenografts
AT generalidaniele platinumsensitivityanddnarepairinarecentlyestablishedpanelofpatientderivedovariancarcinomaxenografts
AT giavazziraffaella platinumsensitivityanddnarepairinarecentlyestablishedpanelofpatientderivedovariancarcinomaxenografts
AT damiagiovanna platinumsensitivityanddnarepairinarecentlyestablishedpanelofpatientderivedovariancarcinomaxenografts